Maxillofacial haemorrhagic symptoms in emergency department patients: impact of antithrombotics
- PMID: 38197899
- PMCID: PMC11035474
- DOI: 10.1007/s00068-023-02428-0
Maxillofacial haemorrhagic symptoms in emergency department patients: impact of antithrombotics
Abstract
Purpose: To investigate the effect of antithrombotics on the occurrence of maxillofacial haemorrhagic symptoms, and to determine if these haemorrhagic symptoms are predictors of maxillofacial fractures.
Method: A prospective cohort study was conducted of consecutive patients with maxillofacial trauma who had been admitted to the emergency department of four hospitals in the Netherlands. This study compared five haemorrhagic symptoms (peri-orbital haematoma, raccoon eyes, epistaxis, subconjunctival ecchymosis, and intra-oral haematoma) between patients not-using (NUA) and using (UA) of antithrombotics, and whether these maxillofacial haemorrhagic symptoms served as predictors for maxillofacial fractures.
Results: Out of the 1005 patients, 812 (81%) belonged to the NUA group, and 193 (19%) to the UA group. UA patients exhibited higher frequencies of peri-orbital hematoma (54% vs. 39%, p < 0.001), raccoon eyes (10% vs. 5%, p = 0.01), and subconjunctival ecchymoses (16% vs. 7%, p < 0.001). In NUA, peri-orbital hematoma (OR = 2.5, p < 0.001), epistaxis (OR = 4.1, p < 0.001), subconjunctival ecchymosis (OR = 2.3, p = 0.02), and intra-oral hematoma (OR = 7.1, p < 0.001) were significant fracture predictors. Among UA, peri-orbital hematoma (OR = 2.2, p = 0.04), epistaxis (OR = 5.4, p < 0.001), subconjunctival ecchymosis (OR = 3.7, p = 0.008), and intra-oral hematoma (OR = 22.0, p < 0.001) were significant fracture predictors.
Conclusion: Maxillofacial haemorrhagic symptoms were observed more frequently in the UA group than in the NUA group. However, in both groups, maxillofacial haemorrhagic symptoms appear to be predictors of maxillofacial fractures. Caution is warranted in attributing these symptoms solely to antithrombotic use during emergency department assessments.
Keywords: Antithrombotics; Epistaxis; Intra-oral haematoma; Maxillofacial haematoma; Maxillofacial trauma; Peri-orbital haematoma; Subconjuctival eccymosis.
© 2024. The Author(s).
Conflict of interest statement
Pieter Date van der Zaag, Stephanie Geurts, Romke Rozema, Inge H.F. Reininga, Baucke van Minnen and the REDUCTION study group members declare that they have no conflict of interest.
Figures
Similar articles
-
Epidemiology of maxillofacial trauma in elderly patients receiving oral anticoagulant or antithrombotic medication; a Swiss retrospective study.BMC Emerg Med. 2024 Jul 18;24(1):121. doi: 10.1186/s12873-024-01039-1. BMC Emerg Med. 2024. PMID: 39020294 Free PMC article.
-
Impact of antithrombotic treatment in orbital haematoma.J Stomatol Oral Maxillofac Surg. 2018 Dec;119(6):489-492. doi: 10.1016/j.jormas.2018.05.004. Epub 2018 May 21. J Stomatol Oral Maxillofac Surg. 2018. PMID: 29792939
-
Ecchymosis and/or haematoma formation after prophylactic administration of subcutaneous enoxaparin in the abdomen or arm of the critically ill patient.Enferm Intensiva (Engl Ed). 2018 Jan-Mar;29(1):4-13. doi: 10.1016/j.enfi.2017.11.001. Epub 2018 Jan 9. Enferm Intensiva (Engl Ed). 2018. PMID: 29326015 Clinical Trial. English, Spanish.
-
Hemorrhagic Events in Adult Celiac Disease Patients. Case Report and Review of the Literature.J Gastrointestin Liver Dis. 2018 Mar;27(1):93-99. doi: 10.15403/jgld.2014.1121.271.cld. J Gastrointestin Liver Dis. 2018. PMID: 29557421 Review.
-
Management of epistaxis in the oral and maxillofacial surgery setting: An update on current practice.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Jan;95(1):23-9. doi: 10.1067/moe.2003.10. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003. PMID: 12539023 Review.
References
-
- Zorginstituut Nederland/GIP. Zorginstituut Nederland/ GIPdatabank. Aantal gebruikers 2016–2020 voor ATC-subgroep B01. 2023. https://www.gipdatabank.nl/databank?infotype=g&label=00-totaal&tabel=B_0.... Accessed 12 Jan 2023.
-
- World Health Organization (WHO). Number of persons aged 60 and over. 2022. https://platform.who.int/data/maternal-newborn-child-adolescent-ageing/i.... Accessed 12 Jan 2023.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources